114 related articles for article (PubMed ID: 10864923)
1. A region in domain II of the urokinase receptor required for urokinase binding.
Bdeir K; Kuo A; Mazar A; Sachais BS; Xiao W; Gawlak S; Harris S; Higazi AA; Cines DB
J Biol Chem; 2000 Sep; 275(37):28532-8. PubMed ID: 10864923
[TBL] [Abstract][Full Text] [Related]
2. Soluble human urokinase receptor is composed of two active units.
Higazi AA; Mazar A; Wang J; Quan N; Griffin R; Reilly R; Henkin J; Cines DB
J Biol Chem; 1997 Feb; 272(8):5348-53. PubMed ID: 9030610
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor.
Higazi A; Cohen RL; Henkin J; Kniss D; Schwartz BS; Cines DB
J Biol Chem; 1995 Jul; 270(29):17375-80. PubMed ID: 7615542
[TBL] [Abstract][Full Text] [Related]
4. The kringle stabilizes urokinase binding to the urokinase receptor.
Bdeir K; Kuo A; Sachais BS; Rux AH; Bdeir Y; Mazar A; Higazi AA; Cines DB
Blood; 2003 Nov; 102(10):3600-8. PubMed ID: 12881310
[TBL] [Abstract][Full Text] [Related]
5. Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins.
Higazi AA; Upson RH; Cohen RL; Manuppello J; Bognacki J; Henkin J; McCrae KR; Kounnas MZ; Strickland DK; Preissner KT; Lawler J; Cines DB
Blood; 1996 Jul; 88(2):542-51. PubMed ID: 8695802
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the single-chain urokinase-urokinase receptor complex activity by plasminogen and fibrin: novel mechanism of fibrin specificity.
Higazi AA; Ajawi F; Akkawi S; Hess E; Kuo A; Cines DB
Blood; 2005 Feb; 105(3):1021-8. PubMed ID: 15353482
[TBL] [Abstract][Full Text] [Related]
7. Lysis of plasma clots by urokinase-soluble urokinase receptor complexes.
Higazi AA; Bdeir K; Hiss E; Arad S; Kuo A; Barghouti I; Cines DB
Blood; 1998 Sep; 92(6):2075-83. PubMed ID: 9731065
[TBL] [Abstract][Full Text] [Related]
8. Regulation of single chain urokinase binding, internalization, and degradation by a plasminogen activator inhibitor 1-derived peptide.
Zhang L; Strickland DK; Cines DB; Higazi AA
J Biol Chem; 1997 Oct; 272(43):27053-7. PubMed ID: 9341144
[TBL] [Abstract][Full Text] [Related]
9. Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1.
Higazi AA; Mazar A; Wang J; Reilly R; Henkin J; Kniss D; Cines D
Blood; 1996 May; 87(9):3545-9. PubMed ID: 8611676
[TBL] [Abstract][Full Text] [Related]
10. Unesterified long chain fatty acids inhibit the binding of single chain urokinase to the urokinase receptor.
al-Roof Higazi A; Aceto JF; Kniss D; Upson R; Cohen R; Dichek DA; Cines DB
Biochemistry; 1996 May; 35(21):6884-90. PubMed ID: 8639640
[TBL] [Abstract][Full Text] [Related]
11. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
Ploug M
Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
[TBL] [Abstract][Full Text] [Related]
12. Regulation of single chain urokinase by small peptides.
Higazi A al-R ; Cines D
Thromb Res; 1996 Nov; 84(4):243-52. PubMed ID: 8948049
[TBL] [Abstract][Full Text] [Related]
13. Novel interactions between urokinase and its receptor.
Shliom O; Huang M; Sachais B; Kuo A; Weisel JW; Nagaswami C; Nassar T; Bdeir K; Hiss E; Gawlak S; Harris S; Mazar A; Higazi AA
J Biol Chem; 2000 Aug; 275(32):24304-12. PubMed ID: 10801829
[TBL] [Abstract][Full Text] [Related]
14. Random peptide bacteriophage display as a probe for urokinase receptor ligands.
Fong S; Doyle MV; Goodson RJ; Drummond RJ; Stratton JR; McGuire L; Doyle LV; Chapman HA; Rosenberg S
Biol Chem; 2002 Jan; 383(1):149-58. PubMed ID: 11928809
[TBL] [Abstract][Full Text] [Related]
15. Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase.
Chang AW; Kuo A; Barnathan ES; Okada SS
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1855-60. PubMed ID: 9848876
[TBL] [Abstract][Full Text] [Related]
16. Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile.
Murciano JC; Higazi AA; Cines DB; Muzykantov VR
J Control Release; 2009 Nov; 139(3):190-6. PubMed ID: 19616049
[TBL] [Abstract][Full Text] [Related]
17. Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains.
Behrendt N; Ronne E; Dano K
J Biol Chem; 1996 Sep; 271(37):22885-94. PubMed ID: 8798468
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the ternary complex formation of human urokinase with the separated two domains of its receptor.
Oda M; Shiraishi A; Hasegawa M
Eur J Biochem; 1998 Sep; 256(2):411-8. PubMed ID: 9760182
[TBL] [Abstract][Full Text] [Related]
19. A sequence-dependent monoclonal antibody specific for single-chain urokinase.
Charpie JR; Haber E; Matsueda GR
Biochem Biophys Res Commun; 1988 Apr; 152(2):910-5. PubMed ID: 3365258
[TBL] [Abstract][Full Text] [Related]
20. Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization.
Sidenius N; Andolfo A; Fesce R; Blasi F
J Biol Chem; 2002 Aug; 277(31):27982-90. PubMed ID: 12034711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
